nirogacestat
springworks therapeutics
['congrat', 'defi ', 'sarcoma', 'nirogacestat']
#esmo22 is hosting results of defi phase iii trial in rare desmoid tumor with nirogacestat: it met it s primary endpoint with significant and early pfs benefit!
congratulations to bernd kasper and investigators . this is a clinical practice changing! #sarcoma 
Independent & international experts in #Sarcoma. #MedEd communicators, keeping you up to date with research & medical news in Sarcoma. Part of https://t.co/qM8Tca8PQX